Form 4: Myomo Inc. Chief Medical Officer Harry Kovelman Reports Stock Sale

Harry Kovelman, Chief Medical Officer of Myomo, Inc., reported the sale of 2,029 shares of common stock at an average price of $4.012 on September 3, 2024, and a further transaction on September 4, 2024, to cover income taxes.

Summary

• On September 3, 2024, Harry Kovelman, the Chief Medical Officer of Myomo, Inc., sold 2,029 shares of common stock at an average price of $4.012 per share.
• The shares were sold in multiple lots with prices ranging from $4.00 to $4.03.
• Following this transaction, Kovelman directly owns 130,395 shares of Myomo, Inc.
• On September 4, 2024, Kovelman sold 139 shares at $3.89 to cover income taxes on vesting restricted stock units.
• Following this transaction, Kovelman directly owns 130,256 shares of Myomo, Inc.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an officer. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.

Stakeholder Impact

• The stock sale by a company officer may be of interest to shareholders, as it provides insight into management's perspective on the company's stock.

Key Dates